Skip to main content
Log in

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Montgomery SA, Reimitz PE, Zivkov M. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study. Int Clin Psychopharmacol. 1998 Mar; 13(2): 63–73

    Article  PubMed  CAS  Google Scholar 

  2. Hartmann PM. Mirtazapine: a newer antidepressant. Am Fam Physician 1999 Jan 1; 59(1): 159–61

    PubMed  CAS  Google Scholar 

  3. Shakir SAW. Prescription-Event Monitoring. In: Strom B, editor. Pharmacoepidemiology. 4th ed. Chichester, UK: John Wiley & Sons Ltd, 2005: 203–16

    Google Scholar 

  4. Shakir SAW. Causality and Correlation in Pharmacovigilance. In: Waller P, Talbot J, editors. Stephens’ Detection of New Adverse Drug Reactions. 5th ed. Chichester, UK: John Wiley & Sons Ltd, 2004: 330–43

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cobert, J., Ferreira, G.L.C., Wilton, L. et al. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 926 (2006). https://doi.org/10.2165/00002018-200629100-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200629100-00023

Keywords

Navigation